Study on the impact of comprehensive geriatric assessment on anxiety and depression in chronic obstructive pulmonary disease patients

Table 1 Comparison of general information of patients, mean ± SD

Group	Experimental group	Control group	F/t	P value
Age (yr)	65.00 ± 5.27	65.77 ± 3.13	-0.69	0.50
Gender (Male/Female)	12/18	13/ 17	-0.77	0.45
Body mass index	24.54 ± 1.83	24.13 ± 2.11	0.81	0.42
Smoking history (Pack/Year)	15/15	14/ 16	0.79	0.43
High blood pressure (Yes/No)	13/17	12/18	-0.77	0.45
Diabetes (Yes/No)	7/23	6/24	-0.77	0.45
Glycosylated hemoglobin (%)	6.66 ± 0.50	6.54 ± 0.55	0.89	0.38
Total cholesterol (mmoL/L)	5.64 ± 0.73	5.84 ± 0.69	-1.07	0.29
Triglyceride (mmoL/L)	1.82 ± 0.51	1.74±0.54	0.60	0.55
Low density lipoprotein (mmoL/L)	3.34 ± 0.54	3.67 ± 0.45	-2.55	0.01
Phospholipid protein A1 (g/L)	1.19 ± 0.22	1.12 ± 0.18	1.52	0.13
Phospholipid protein B (g/L)	1.71 ± 0.35	1.67 ± 0.37	0.43	0.67
Lipoprotein (mg/dL)	127.22 ± 7.98	134.39 ± 18.60	-1.94	0.06

Table 2 Comparison of clinical symptoms and quality of life, mean ± SD

Group	CAT score (admission)	CAT score (discharge)
Control group	24.20 ± 3.68	22.4 ± 2.4
Observation group	23.97 ± 2.75	18.10 ± 2.28
t	-0.28	-7.11
P value	0.78	< 0.01

CAT: Chronic obstructive pulmonary disease assessment test.

Table 3 Comparison of anxiety and depression, mean ± SD

Group	HAMA score (admission)	HAMA score (discharge)	HAMD score (admission)	HAMD score (discharge)
Control group	15.1 ± 1.67	11.93 ± 1.23	14.63 ± 2.47	11.83 ± 2.31
Observation group	14.23 ± 2.32	8.57 ± 1.55	13.6 ± 2.36	7.8 ± 1.45
t	-1.66	-9.33	-1.66	-8.11
P value	0.10	< 0.01	0.10	< 0.01

HAMA: Hamilton Anxiety Rating Scale; HAMD: Hamilton Depression Rating Scale.

Table 4 Comparison of symptom relief time and hospitalization time, mean ± SD

Group	Symptom relief time (day)	Hospital stay (day)
Control group	5.27 ± 1.48	10.53 ± 2.30
Observation group	7.97 ± 1.65	10.23 ± 1.81
t	6.66	-0.56
P value	< 0.01	0.58

Table 5 Comparison of complication rates, n (%)

Group	Complications occurred during the study period	Types of complications
Control group	4 cases (13.3)	Respiratory tract infection (2 cases), heart failure (1 case), pneumothorax (1 case)
Observation group	2 cases (6.7)	Respiratory tract infection (1 case), pulmonary embolism (1 case)
t	1.45	2.63
P value	< 0.01	< 0.01